Farmasøytiske sammensetninger og anvendelse av disse i behandling av kreft

The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound t...

Full description

Saved in:
Bibliographic Details
Main Authors Adelman, Daniel C, Silverman, Jeffrey A, Satoshi, Nakao, Masaru, Higaki
Format Patent
LanguageNorwegian
Published 25.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound to the patient in a dose of 10 mg/m 2 to 100 mg/m 2 .
Bibliography:Application Number: NO20060004647